DKK1 and Miyoshi myopathy: The production of IL-6 was not influenced by any treatments whereas the one of VEGF was reduced by all treatments, the one of GDF-15 and DKK1 was reduced by Bortezomib-based and Thalidomide-based treatments in MM BM-MSCs compared to untreated MM BM-MSCs.